Literature DB >> 18353515

Practicing research ethics: private-sector physicians & pharmaceutical clinical trials.

Jill A Fisher1.   

Abstract

This paper focuses on constructions of research ethics by primary care physicians in the USA as they engage in contract research for the pharmaceutical industry. Drawing first on historical studies of physicians as investigators and then on 12 months of qualitative fieldwork in the Southwestern US, this paper analyzes the shifting, contextualized ethics that shape physicians' relationships with patients/subjects and pharmaceutical companies. Just as physicians followed professional codes of ethics prior to the codification of acceptable research conduct in the 1980s, physicians today continue to develop tacit systems of research ethics. This paper argues that private-sector physicians primarily conceptualize their ethical conduct in relation to the pharmaceutical companies hiring them, not to human subjects they enroll in clinical trials. This is not to say that these physicians do not follow the formal U.S. regulation to protect human subjects, but rather that their financial relationships with the pharmaceutical industry have a greater influence on their identities as researchers and on their constructions of their ethical responsibilities.

Entities:  

Mesh:

Year:  2008        PMID: 18353515      PMCID: PMC2430597          DOI: 10.1016/j.socscimed.2008.02.001

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  24 in total

1.  Uneasy alliance--clinical investigators and the pharmaceutical industry.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

2.  Ethics review for sale? Conflict of interest and commercial research review boards.

Authors:  T Lemmens; B Freedman
Journal:  Milbank Q       Date:  2000       Impact factor: 4.911

3.  Impure science: AIDS, activism, and the politics of knowledge.

Authors:  S Epstein
Journal:  Med Soc (Berkeley)       Date:  1996

4.  The invisible hand in clinical research: the study coordinator's critical role in human subjects protection.

Authors:  Arlene M Davis; Sara Chandros Hull; Christine Grady; Benjamin S Wilfond; Gail E Henderson
Journal:  J Law Med Ethics       Date:  2002       Impact factor: 1.718

Review 5.  The clinician as investigator: participating in clinical trials in the practice setting.

Authors:  Ellis W Lader; Christopher P Cannon; E Magnus Ohman; L Kristin Newby; Daniel P Sulmasy; Robyn J Barst; Joan M Fair; Marcus Flather; Jane E Freedman; Robert L Frye; Mary M Hand; Robert L Jesse; Frans Van de Werf; Fernando Costa
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

6.  How can we help? From "sociology in" to "sociology of" bioethics.

Authors:  Raymond De Vries
Journal:  J Law Med Ethics       Date:  2004       Impact factor: 1.718

7.  Gag clauses in clinical-trial agreements.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2005-05-26       Impact factor: 91.245

8.  Co-ordinating 'ethical' clinical trials: the role of research coordinators in the contract research industry.

Authors:  Jill A Fisher
Journal:  Sociol Health Illn       Date:  2006-09

9.  Procedural misconceptions and informed consent: insights from empirical research on the clinical trials industry.

Authors:  Jill A Fisher
Journal:  Kennedy Inst Ethics J       Date:  2006-09

10.  Volunteer human subjects' understandings of their participation in a biomedical research experiment.

Authors:  Norma Morris; Brian Bàlmer
Journal:  Soc Sci Med       Date:  2005-08-08       Impact factor: 4.634

View more
  2 in total

1.  Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials.

Authors:  Jill A Fisher
Journal:  Sci Technol Human Values       Date:  2015-03-01

2.  United States private-sector physicians and pharmaceutical contract research: a qualitative study.

Authors:  Jill A Fisher; Corey A Kalbaugh
Journal:  PLoS Med       Date:  2012-07-24       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.